Regeneron Pharmaceuticals Inc

2 de jul. de 2026, 23:26 UTC

Regeneron Pharmaceuticals Inc shares are lower in after-market hours, despite a lower-than-expected jobs report easing rate hike fears and boosting sentiment for some risk assets.

1 de jul. de 2026, 19:16 UTC

Regeneron Pharmaceuticals is trading higher, reflecting positive biotechnology sector performance. The stock remains above its 20-day moving average and near a one-month peak.

30 de jun. de 2026, 23:16 UTC

Regeneron Pharmaceuticals shares remain roughly flat in after-market trading, following three consecutive sessions of declines and no specific news identified.

29 de jun. de 2026, 23:06 UTC

Regeneron Pharmaceuticals will join the FDA's PreCheck Pilot Program to enhance domestic drug manufacturing. Shares are trading lower in after-market hours.

26 de jun. de 2026, 23:36 UTC

Regeneron Pharmaceuticals Inc shares are trading higher in after-market hours, moving within a notable range above their 20-day moving average.

25 de jun. de 2026, 23:16 UTC

Regeneron Pharmaceuticals Inc shares are lower in after-market hours, retracing from an early peak following five consecutive daily gains. No specific news was identified.

24 de jun. de 2026, 23:01 UTC

Regeneron Pharmaceuticals Inc shares are lower after-market hours, continuing a decline since Wednesday's close amid positive sentiment in the financial sector.

23 de jun. de 2026, 23:06 UTC

Regeneron Pharmaceuticals Inc shares are trading lower in after-market hours. Broader market trends may be influencing the stock's movement amid European market declines.

22 de jun. de 2026, 19:56 UTC

Regeneron Pharmaceuticals' cemdisiran submissions accepted by the FDA and European Medicines Agency. Shares are gaining amid positive regulatory developments.

18 de jun. de 2026, 23:51 UTC

Regeneron Pharmaceuticals traded roughly flat in after-market hours, reflecting a slight decline since Thursday's close and remaining near the lower end of its one-month range.

17 de jun. de 2026, 19:53 UTC

Regeneron Pharmaceuticals is declining in Wednesday's session, despite positive U.S. retail sales data. Shares remain below their 20-day moving average.

16 de jun. de 2026, 19:16 UTC

Regeneron Pharmaceuticals Inc shares are lower today, with no specific news identified. Broader market sentiment may be affected by recent economic data.

15 de jun. de 2026, 13:36 UTC

Regeneron Pharmaceuticals Inc shares are lower in pre-market hours. The stock is near the lower end of its one-month range, indicating routine price action.

13 de jun. de 2026, 00:01 UTC

Regeneron Pharmaceuticals shares are modestly higher in after-market trading, though no specific news was identified to explain the movement.

12 de jun. de 2026, 19:16 UTC

Shares of Regeneron Pharmaceuticals are modestly higher today, gaining traction after a flat start. The stock remains below its 20-day moving average.

11 de jun. de 2026, 23:02 UTC

Regeneron Pharmaceuticals shares are higher in after-market trading, rebounding from earlier fluctuations despite no specific news to explain the movement.

10 de jun. de 2026, 23:11 UTC

Regeneron Pharmaceuticals is trading higher in after-market hours, supported by a rise in the Biotechnology sub-sector. The stock remains near its one-month low.

9 de jun. de 2026, 19:56 UTC

Regeneron Pharmaceuticals shares are higher following WHO's endorsement of its antibody therapy maftivimab for clinical trials against Bundibugyo ebolavirus.

8 de jun. de 2026, 23:51 UTC

Regeneron Pharmaceuticals shares are higher in after-market trading, recovering from earlier lows amid broader market dynamics influenced by recent U.S. jobs data.

5 de jun. de 2026, 20:07 UTC

Regeneron Pharmaceuticals shares are higher as Teva launches AHZANTIVE, a biosimilar to Eylea, enhancing its ophthalmology portfolio and impacting Regeneron's competitive position.

4 de jun. de 2026, 19:56 UTC

Regeneron Pharmaceuticals is gaining momentum ahead of presentations at major medical conferences in June, showcasing new clinical data on key therapies.

3 de jun. de 2026, 23:01 UTC

Regeneron Pharmaceuticals shares are higher in after-market trading, following a session peak. No specific news was identified to explain the movement.

2 de jun. de 2026, 23:21 UTC

Regeneron Pharmaceuticals is trading higher in after-market hours, driven by gains in the Biotechnology sub-sector, marking a notable change from recent performance.

1 de jun. de 2026, 20:03 UTC

Regeneron Pharmaceuticals is under pressure following an investigation announcement by Bronstein, Gewirtz & Grossman, LLC, amid concerns over trial results. Shares are trading lower.

29 de mai. de 2026, 20:05 UTC

Regeneron Pharmaceuticals shares declined following the WHO's recommendation to evaluate maftivimab amid an Ebola outbreak in the Democratic Republic of the Congo and Uganda.

28 de mai. de 2026, 23:02 UTC

Regeneron Pharmaceuticals shares rise after WHO recommends maftivimab for use against the Bundibugyo ebolavirus outbreak in Africa.

27 de mai. de 2026, 23:21 UTC

Regeneron Pharmaceuticals shares are higher in after-market trading, recovering from recent declines but remain below the 20-day moving average. No specific news was identified.

26 de mai. de 2026, 23:06 UTC

Regeneron Pharmaceuticals Inc shares are lower in after-market hours, continuing a recent trend of declines amid broader market weakness and no specific news identified.

22 de mai. de 2026, 19:37 UTC

Regeneron Pharmaceuticals shares are lower today amid investor caution following an investigation into potential claims related to prior trial results.